The price keeps moving along the downtrend channel. I wonder what it takes to break this resistance.
Stormy waters seems to be over for the stock after controversial and debated earnings report followed by expiration of lock-up period. Palantir is much like Microsoft in 90s. Everyone understands the importance of data in the era when business is made @ the speed of thought. Harnessing the power of data, though, is not an easy task at all. There are a lot of...
A lot of bets were made towards the earnings day, which in its turn is linked to lock-up expiration period (3 days after the earnings). The D-day is about to play out next week, which will also "coincide" with Feb option expiration. After short & gamma squeeze drama with BANG stocks ($BB, $AMC, $NOK, $GME) earlier in the year, the frenetic market activity...
Alerts for breaking the downtrend and 0.38 fib-level: $28-28.5 Target 1: $33 Target 2: $38 Target 3: $43 Target end 2021: $50 as per analysts
Update to my previous post: Short-squeeze frenzy ignited volatility and catapulted the stock new consolidation level around $35 as point of control. Further play will be much driven by earnings and lock-up period expiration on Feb 16 or 17. Potentially, we may see pull back to key support level of $31 with possible false break-outs to $28 and in worst case...
The main thesis is that $REGN pattern is similar to $ABBV; though it needed a catalyst for reversal. Today's news is the one + earnings next week. Target 1: $575 - short-term (earnings as catalyst) Target 2: $615 - mid-term (post-earnings till next earnings) Target 3: $650 - mid-year
Break-out from the previous long consolidation, the stock is moving towards bull flag/pennant formation with 31 as support and 36 as resistance. Important milestone: earnings and lock-up expiration 3 days later; which promises potential volatility from now.
Bulls energy was not enough to break out over $130-131 resistance level; though intraday break-outs occurred. Consolidation continues with retracement to lower $120-115 range. Entering below the resistance is risky though. And the assumption above of course remains a hypothesis. Therefore, I'm waiting for confirmation above $132 resistance with bullish...
Though stock is deemed to be overvalued fundamentally, it is floating upward forming the channel. Based on the trend pattern and fib level - this week it may test 154 level.
Classic case of fib level retracements Target 1: $140 Target 2: $150 Target 3: $160 There are resistance levels to break between the targets. RSI and MACD suggest there's energy to break towards target #3 prior to earnings. Considering PEG, future outlook, product pipeline, news storyline and environment - MRNA has a good potential for 2021. Earnings call...
Symmetrical triangle break-out Target 1: $28 Target 2: $31 Target 3: $34
$35-35.5 - breaking this level opens the road to target 1: $43 Target 2: 48 is potential if trend is broken
Depending on Q4 earnings results and guidance, the stock may target $50. Estimated 1.4 EPS for 2020 implies $80 @ current PE level of 57. Overall, the prospects are good for this company. However, the road ahead will be bumpy, especially with IPO lock-up period ending in late March. Earnings announcement date is expected on Feb 09; however, tradingview charts...
Hypothesis: side move to continue before monthly options expirations
My hypothesis for next few weeks. Lock-up period expiration and earnings can dramatically change the layout though.
Strong fundamentals. Risks are related to the nature of the business However, as the pandemic folds and healthcare sector accelerates, companies like $BIO, $QDEL, $LH are the ones behind the scenes.
As it was laid out previously - the retest of major support line @ 37 with false break last week is done. Bouncing upward towards trendline and major fib resistance @ 43. Gaming season will continue fueled by stimulus. PS. Refer to related posts
Consolidation below major trend line. Stifel is one of beneficiaries of massive stock market frenzy. Doji candles hint that consolidation since Dec 15 is potentially preparing to break out. Target 1: 55-56 Target 2: 60-61 Likes and comments are welcome.